Results 221 to 230 of about 3,204,619 (291)
Development of a clinical prediction model to guide the selective use of SPECT/CT in papillary thyroid cancer. [PDF]
Zhu L, Son J, Wang L, Hou H, Ahn BC.
europepmc +1 more source
The WHO Classification of Genetic Tumour Syndromes: Considerations for Genetics
The WHO Classification of Tumours underpins the diagnosis of neoplastic conditions. The new WHO classification of genetic tumour syndromes (GTS) provides international standards for their diagnosis. This diagram highlights the chromosomal distribution of the genes involved in the GTS covered in this classification.
Ian A. Cree +18 more
wiley +1 more source
The association of Hashimoto's thyroiditis with central lymph node metastasis in papillary thyroid cancer: a retrospective cross-sectional study. [PDF]
Wen L +6 more
europepmc +1 more source
This quality assurance project confirms that thyroid FNAC is a reliable tool for assessing the risk of malignancy (ROM), with ROM rates aligning with published data. However, cytology team changes can reveal interobserver variability and shift category distribution and malignancy rates, underlining the need for ongoing quality assurance and training ...
Pauline Kuerten +5 more
wiley +1 more source
Integrated Cytokine, Metabolic, and Proliferative Profiling Reveals Divergent Metabolic and Proliferative Responses in Papillary Thyroid Cancer Cells. [PDF]
Buczyńska-Backiel A +7 more
europepmc +1 more source
The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 9, September 2026.
Luo‐Wei Chan +3 more
wiley +1 more source
S1 guideline sweat gland carcinoma
Summary The current classification of sweat gland carcinomas is based on histomorphological characteristics and distinguishes between more than 20 entities. Most patients are older, but some subtypes also affect middle‐aged and younger patients. The majority of tumors arise de novo. Sweat gland carcinomas have nonspecific clinical features.
Mirjana Ziemer +19 more
wiley +1 more source
Factors influencing postoperative thyroid-stimulating hormone suppression therapy in low-risk papillary thyroid cancer after lobectomy. [PDF]
Dong B, Xiao S, Wang Z, Wang Y.
europepmc +1 more source
SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley +1 more source

